Skip to Main Content

Paper Details

Chromatin modifications as therapeutic targets in MLL-rearranged leukemia.
Trends Immunol
48
2012
BRD4, DOT1L, MLL, MLL fusion gene, MLL-rearranged leukemia, MLL-rearranged leukemias, acetyl, acetyl-histone binding protein, bromodomain containing protein 4, cancers, disruptor of telomeric silencing 1-like, histone methyltransferase, leukemia, malignancies
Author NameAffiliation
Aniruddha J DeshpandeChildren's Hospital, Harvard Medical School
  • 1 - 1

Datasets

Release 1.2